Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning.
We’ve got a lot of new data to dig into, so let’s get straight to it. Medicare delays pilot for covering obesity drugs One of the key health care accomplishments the Trump administration wanted to claim was securing coverage of obesity drugs for seniors.
That plan is now unraveling. Continue to STAT+ to read the full story...
STAT News published a clinical update in Research Highlights on 22 Apr 2026.
The item focuses on STAT+: The latest biotech news: RevMed, Roche, Kyverna CAR-T therapy.
Review the original article for the full source wording and details.